FF-A/10, Vrajvatika
Gotri Road, Vadodara
Gujarat, India – 39110.
Molecule | Strength / Volume | Formulation Description |
Gliclazide | 80 mg | Tablet |
Gliclazide + Metformin | 30mg + 500mg | Tablet |
Glimepride | 1mg, 2mg | Tablet |
Glimepiride + Metformin HCL | 1 mg + 500 mg & 2 mg + 500 mg | Normal & Sustained Release Tablet |
Glibenclamide + Metformin | 5mg + 500mg | Tablet |
Insulin 30/70 | 40 IU 30/70 R/NPH 10ml | Injectable |
Insulin 30/70 | 100 IU 30/70 R/NPH 10ml | Injectable |
Insulin 50/50 | 40 IU 50/50 R/NPH 10ml | Injectable |
Insulin 50/50 | 100 IU 50/50 R/NPH 10ml | Injectable |
Insulin | 40 IU NPH 10ml | Injectable |
Insulin | 40 IU R 10ml | Injectable |
Insulin | 100 IU NPH 10ml | Injectable |
Insulin | 100 IU R 10ml | Injectable |
Linagliptin | 5mg | Tablet |
Metformin | 500 mg & 850 mg | Extended Release Tablet |
Pioglitazone | 30mg, 45mg | Tablet |
Sitagliptin | 50 mg &100 mg | Tablet |
Teneligliptin | 20mg | Tablet |
Vildagliptin | 50mg, 100mg | Tablet |
Vildagliptin + Metformin | 50mg+500mg | Tablet |
Voglibose | 0.2 mg & 0.3 mg | Tablet |
Voglibose + Metformin | 0.2mh+500mg, 0.3mg+500mg | Tablet |